Stem cell co Cellect files for Nasdaq offering – Globes
Globes |
Stem cell co Cellect files for Nasdaq offering
Globes Israeli company Cellect Biotechnology Ltd. (TASE: CLBD), which is developing a method for selection of stem cells, has submitted a prospectus for an offering of shares in the US as part of its plan for dual listing on Nasdaq and the Tel Aviv Stock … |
